Guidelines for surfactant replacement therapy in neonates

ASEM 文献综述

Official Canadian Paediatric Society document (2021) on “Guidelines for surfactant replacement therapy in neonates”. Abstract Surfactant replacement therapy (SRT) plays a pivotal role in the management of neonates with respiratory distress syndrome (RDS) because it improves survival and reduces respiratory morbidities. With the increasing use of non-invasive ventilation as the primary mode of respiratory support for preterm infants at delivery, prophylactic surfactant is no longer beneficial. For infants with worsening RDS, early r.

此摘要有助于您识别文档。对于临床建议，请始终查阅官方现行版本及其更新日期。